196 related articles for article (PubMed ID: 33798634)
1. Newly developed radioimmunoassay for Human Angiotensin-(1-12) measurements in plasma and urine.
Ahmad S; Punzi HA; Wright KN; Groban L; Ferrario CM
Mol Cell Endocrinol; 2021 Jun; 529():111256. PubMed ID: 33798634
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the renin-angiotensin system.
Soler MJ; Batlle D
Mol Cell Endocrinol; 2021 Jun; 529():111268. PubMed ID: 33819521
[No Abstract] [Full Text] [Related]
3. Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene.
Ferrario CM; VonCannon J; Jiao Y; Ahmad S; Bader M; Dell'Italia LJ; Groban L; Varagic J
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H995-1002. PubMed ID: 26873967
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension.
Ferrario CM; Iyer SR; Burnett JC; Ahmad S; Wright KN; VonCannon JL; Saha A; Groban L
Hypertension; 2021 Mar; 77(3):882-890. PubMed ID: 33461312
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin(1-7) in the spontaneously hypertensive rat.
Kohara K; Brosnihan KB; Ferrario CM
Peptides; 1993; 14(5):883-91. PubMed ID: 8284265
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of the renal angiotensin-converting enzyme.
Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
[TBL] [Abstract][Full Text] [Related]
7. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects.
Ferrario CM; Martell N; Yunis C; Flack JM; Chappell MC; Brosnihan KB; Dean RH; Fernandez A; Novikov SV; Pinillas C; Luque M
Am J Hypertens; 1998 Feb; 11(2):137-46. PubMed ID: 9524041
[TBL] [Abstract][Full Text] [Related]
8. Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.
Reyes S; Varagic J; Ahmad S; VonCannon J; Kon ND; Wang H; Groban L; Cheng CP; Dell'Italia LJ; Ferrario CM
Curr Hypertens Rep; 2017 Feb; 19(2):16. PubMed ID: 28233239
[TBL] [Abstract][Full Text] [Related]
9. Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1-12) substrate.
Ahmad S; Wright KN; Sun X; Groban L; Ferrario CM
Biochem Biophys Res Commun; 2019 Oct; 518(4):651-656. PubMed ID: 31466718
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
Bragat AC; Blumenfeld J; Sealey JE
J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
[TBL] [Abstract][Full Text] [Related]
11. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
12. The Angiotensin-(1-12)/Chymase axis as an alternate component of the tissue renin angiotensin system.
Ferrario CM; Groban L; Wang H; Cheng CP; VonCannon JL; Wright KN; Sun X; Ahmad S
Mol Cell Endocrinol; 2021 Jun; 529():111119. PubMed ID: 33309638
[TBL] [Abstract][Full Text] [Related]
13. Differential response of angiotensin peptides in the urine of hypertensive animals.
Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice.
Ansary TM; Urushihara M; Fujisawa Y; Nagata S; Urata H; Nakano D; Hirofumi H; Kitamura K; Kagami S; Nishiyama A
Exp Physiol; 2018 Nov; 103(11):1524-1531. PubMed ID: 30137655
[TBL] [Abstract][Full Text] [Related]
15. Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension.
Devarajan S; Yahiro E; Uehara Y; Habe S; Nishiyama A; Miura S; Saku K; Urata H
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1987-96. PubMed ID: 26432844
[TBL] [Abstract][Full Text] [Related]
16. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Ferrario CM; Averill DB; Brosnihan KB; Chappell MC; Iskandar SS; Dean RH; Diz DI
Kidney Int; 2002 Oct; 62(4):1349-57. PubMed ID: 12234305
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Bohlender J; Bader M; Ménard J; Nussberger J
J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
[TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Campbell DJ; Duncan AM; Kladis A; Harrap SB
J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
[TBL] [Abstract][Full Text] [Related]
19. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
[TBL] [Abstract][Full Text] [Related]
20. Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.
Ferrario CM; Ahmad S; Varagic J; Cheng CP; Groban L; Wang H; Collawn JF; Dell Italia LJ
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H404-14. PubMed ID: 27233763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
